During COVID-19 peaks, some hospitals that experienced high patient volumes scrambled to meet the increased demand for renal replacement therapy (RRT). With nearly one-third of the sickest COVID patients requiring RRT, the pandemic’s early weeks saw supply shortages in some locales, stretching skilled personnel to the breaking point.
The choices some health systems made then could also signal a shift in the way RRT is delivered in the intensive care unit (ICU), favoring shorter bursts of therapy delivered by more
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?